
TGTX EPS Estimates
TG Therapeutics, Inc.
$63.34
-$1.54(-2.37%)
63
Overall
60
Value
66
Tech
65
Quality
Market Cap
$9.57B
Volume
2.09M
52W Range
$26.76 - $68.03
Target Price
$64.14
TGTX EPS estimates: the consensus estimate for TG Therapeutics, Inc.'s current fiscal year is $1.10 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
TGTX EPS Estimates
- EPS estimate, current quarter
- $0.56
- EPS estimate, next quarter
- $0.57
- EPS estimate, current year
- $1.10
- EPS estimate, next year
- $2.86
- EPS growth, 3-year
- +60.35%
| Fiscal year | EPS |
|---|---|
| 2025 | $3.10 |
| 2024 | $0.16 |
| 2023 | $0.09 |
| 2022 | $-1.46 |
| 2021 | $-2.63 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TGTX | $63.34 | -2.4% | 2.09M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |